AGT and Myocardial fibrosis: In vivo, EF-1 mitigated myocardial fibrosis in an AngII model of cardiac fibrosis in both male and female mice, prevented acute cardiomyocyte injury in DOX-treated female mice, and reduced cardiac dilation and cardiac fibrosis in female mice that underwent MI.